TIMP2 and renal cell carcinoma: Studies in renal cell carcinoma (RCC) xenograft models have shown that inhibition of miR-193a-5p levels in tumor-associated macrophage (TAM) exosomes can inhibit tumor progression and metastasis by inhibiting angiogenic mimicry (VM) and upregulating TIMP2 expression (11).